Cargando…
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
It has been 100 years since the first successful clinical use of insulin, yet it remains the only treatment option for type 1 diabetes mellitus (T1DM) patients. Advances in diabetes care, such as insulin analogue therapies and new devices, including continuous glucose monitoring with continuous subc...
Autores principales: | Nagy, Geza, Szekely, Tekla Evelin, Somogyi, Aniko, Herold, Magdolna, Herold, Zoltan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606789/ https://www.ncbi.nlm.nih.gov/pubmed/36312000 http://dx.doi.org/10.4239/wjd.v13.i10.835 |
Ejemplares similares
-
Role and function of granin proteins in diabetes mellitus
por: Herold, Zoltan, et al.
Publicado: (2021) -
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020) -
Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020) -
Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020) -
Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)